A Prospective Single Centre Study Investigating 1KHz/FAST/Microburst Neurostimulation's Effects on PSPS Type-1 Over 24 Months

Abstract

Introduction: Spinal cord stimulation (SCS) is a successful treatment in patients with intractable neuropathic pain. Traditionally it is used in patients who have chronic neuropathic pain following failed back surgery syndrome (FBSS). There is emerging evidence of SCS being used in patients with intractable neuropathic back pain who have not undergone previous spinal surgery (PSPS Type-1).1,2,3 The aim of this study is to investigate the effect of SCS on functionality, quality of life and adverse events in patients comprising this population. The primary objective of this study is to investigate the clinical response following implantation of the Boston Scientific Wavewriter with 1KHz neurostimulation in patients who suffer from chronic neuropathic pain and have not undergone any spinal surgery (PSPS Type 1). The secondary objective will be to investigate the effect of other suitable frequency (FAST/microburst) on pain, functionality, quality of life, medication reduction and adverse events in the study population.